BWXT

AI Memo

BWX

As of 2026-08-21/Confidence medium/Horizon 6‑12m

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-08-21 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

6‑12m

Key catalyst

Raised FY2026 outlook after Q2 results • 2026-08-03

Base target: $180 / p=50% prob

Biggest risk

The thesis depends on continued execution, PCG integration, capacity investment, and conversion of nuclear-market demand into profitable orders. Government and project timing can remain uneven, while insider selling may contribute to near-term volatility.

Invalidation

Break below $125 or thesis failure.

What would change my mind?

BWXT combines strong Q2 execution, rapid Commercial Operations growth, a raised FY2026 outlook, PCG integration, and increased concentration on nuclear national-security and commercial-power markets. The primary-company evidence supports a positive operating trend. [#SEC-8K-2026-08-03]

Research note

Recommendation

—

Confidence

medium

As of

2026-08-21

Base target

$180

p=50%

Bull target

$225

p=25%

Bear target

$125

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Near-term insider-sale and valuation overhang
Capacity and modernization investments across nuclear markets
BWXT combines strong Q2 execution, rapid Commercial Operations growth, a raised FY2026 outlook, PCG integration, and increased concentration on nuclear national-security and commercial-power markets.

BearKey bullets

Commercial nuclear order conversion and government-program timing remain important forward variables, with limited quantified visibility in the packet.
High valuation leaves limited room for execution misses or guidance reductions.
PCG integration, capacity expansion, and modernization spending could pressure margins or free cash flow before benefits scale.

WatchKey bullets

Raised FY2026 outlook after Q2 results

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

6‑12m

Asset

Equity

Trigger

Base case: $180 (p=50%)

Target spread vs base: +25% / -31%

Scenario probabilities

Bull Target: $225 (p=25%)Base Target: $180 (p=50%)Bear Target: $125 (p=25%)

Commentary

Recent coverage is earnings-focused and broadly constructive because of the Q2 results and raised outlook. Social, options, short-interest, employee-review, and analyst-revision data are unavailable or insufficient in the packet, and a verified post-print price-reaction series is not provided. The appropriate stance is positive but monitoring-oriented rather than a high-conviction re-rating call.

As of 2026-08-21 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Near-term insider-sale and valuation overhang
Capacity and modernization investments across nuclear markets

Scenarios

Bull Target (Scenario probability)

$225 / p=25% prob

Base Target (Scenario probability)

$180 / p=50% prob

Bear Target (Scenario probability)

$125 / p=25% prob

Analysis 2026-08-21 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.65

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-08-03
Raised FY2026 outlook after Q2 results
Q2 revenue was $901.6 million, adjusted EPS was $1.07, and adjusted EBITDA was $155.5 million. Management raised FY2026 adjusted EBITDA guidance to $662-$672 million, non-GAAP EPS to $4.70-$4.80, and free cash flow to $345-$360 million. [#SEC-8K-2026-08-03]
Prob 75.00% • Move 7.00% • Priced-in 75.00%
EVENT2026-11-19
PCG integration and commercial nuclear manufacturing expansion
BWXT closed the Precision Components Group acquisition on July 1, 2026, adding a U.S. commercial nuclear component-manufacturing footprint. Execution and contribution should become clearer through the second half of 2026. [#SEC-8K-2026-08-03]
Prob 70.00% • Move 8.00% • Priced-in 55.00%

Short-term Catalysts

Next few weeks

Near-term insider-sale and valuation overhang
2026-08-31
CEO Rex Geveden reported open-market sales totaling approximately 9,737 shares on August 12, 2026. This is not evidence of weaker operations, but may add short-term supply pressure alongside an elevated valuation. [#SEC-FORM4-2026-08-13]
Prob 55% • Move -5% • Priced-in 60%

Long-term Catalysts

Months to a year

Capacity and modernization investments across nuclear markets
2027-06-30
The company is increasing focus and resources on core nuclear national-security and commercial-power markets while investing in manufacturing expansion, capacity, and modernization. Successful conversion of demand into profitable orders would support a longer-duration growth thesis. [#SEC-8K-2026-08-03]
Prob 50% • Move 15% • Priced-in 40%

Risks

Commercial nuclear order conversion and government-program timing remain important forward variables, with limited quantified visibility in the packet.
High valuation leaves limited room for execution misses or guidance reductions.
PCG integration, capacity expansion, and modernization spending could pressure margins or free cash flow before benefits scale.
Recent CEO open-market sales could create short-term sentiment or supply pressure, though they do not establish an operating deterioration signal. [#SEC-FORM4-2026-08-13]

Peers

Symbol	Summary
FLR	Fluor is identified in BWXT's 2025 Form 10-K as a primary Government Operations competitor. Its broader engineering and construction mix makes it an imperfect valuation peer, but it is a more relevant operating comparator than a generic capital-goods company. [#10-K-2026-02-23]
HII	Huntington Ingalls Industries is identified in BWXT's 2025 Form 10-K as a Government Operations competitor. Its naval shipbuilding exposure provides operating context for BWXT's government and nuclear-naval demand, although the business mix differs materially. [#10-K-2026-02-23]
CCJ	Cameco is identified in BWXT's 2025 Form 10-K as a Commercial Operations competitor. Its nuclear-fuel exposure is directly relevant to the commercial nuclear ecosystem, though it is not a like-for-like component-manufacturing peer. [#10-K-2026-02-23]

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-08-21

Loading AI feed…

Symbol

Summary

FLR

Fluor is identified in BWXT's 2025 Form 10-K as a primary Government Operations competitor. Its broader engineering and construction mix makes it an imperfect valuation peer, but it is a more relevant operating comparator than a generic capital-goods company. [#10-K-2026-02-23]

HII

Huntington Ingalls Industries is identified in BWXT's 2025 Form 10-K as a Government Operations competitor. Its naval shipbuilding exposure provides operating context for BWXT's government and nuclear-naval demand, although the business mix differs materially. [#10-K-2026-02-23]

CCJ

Cameco is identified in BWXT's 2025 Form 10-K as a Commercial Operations competitor. Its nuclear-fuel exposure is directly relevant to the commercial nuclear ecosystem, though it is not a like-for-like component-manufacturing peer. [#10-K-2026-02-23]